Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



Identifying Alcohol Use Disorder in Patients With Cirrhosis Reduces 30-Days Readmission Rate
Indexado
WoS WOS:000793411300001
Scopus SCOPUS_ID:85138127177
DOI 10.1093/ALCALC/AGAC015
Año 2022
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Aims Readmission is frequent among patients with cirrhosis and is a complex multifactorial process. To examine the association of alcohol use disorder (AUD) and risk of readmission in patients with alcohol-associated cirrhosis. Methods and Results National Readmission Dataset (2016-2017) was used to extract a retrospective cohort of 53,348 patients with primary or secondary discharge diagnosis code of alcohol-associated cirrhosis with their first admission (26,674 patients with vs. propensity matched 26,674 without a primary or secondary discharge diagnosis code of AUD). Readmission within 30-day was lower (43.9 vs. 48%, P < 0.001) among patients identified to have AUD at the time of discharge. In a conditional logistic regression model, a diagnosis of AUD was associated with 15% reduced odds of 30-day readmission, 0.85 (0.83-0.88). Furthermore, the reason for readmission among patients identified vs. not identified to have AUD was less likely to be liver disease complication. The findings remained similar in a matched cohort of patients where the AUD diagnosis at discharge was listed as one of the secondary diagnoses only. Conclusion Although, our study findings suggest that identification of AUD at the time of discharge among patients hospitalized for alcohol-associated cirrhosis reduces the risk of 30-day readmission, unavailable information on patient counseling, referral for mental health specialist and treatment received for AUD limit the causality assessment. Future studies are needed overcoming the inherent limitations of the database to establish the role of identification and treatment of AUD in reducing readmission and liver decompensation in patients with alcohol-associated cirrhosis.

Revista



Revista ISSN
Alcohol And Alcoholism 0735-0414

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Substance Abuse
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Singal, Ashwani K. - Univ South Dakota - Estados Unidos
Avera Transplant Inst - Estados Unidos
Mckennan Univ Hosp - Estados Unidos
University of South Dakota - Estados Unidos
Avera McKennan Hospital and University Health Center - Estados Unidos
Sanford School of Medicine - Estados Unidos
2 DiMartini, Andrea Mujer Univ Pittsburgh - Estados Unidos
University of Pittsburgh Medical Center - Estados Unidos
University of Pittsburgh School of Medicine - Estados Unidos
3 Leggio, Lorenzo Hombre Natl Inst Hlth - Estados Unidos
Johns Hopkins Univ - Estados Unidos
Georgetown Univ - Estados Unidos
National Institute on Alcohol Abuse and Alcoholism (NIAAA) - Estados Unidos
National Institutes of Health (NIH) - Estados Unidos
Center for Alcohol and Addiction Studies - Estados Unidos
Johns Hopkins School of Medicine - Estados Unidos
Georgetown University Medical Center - Estados Unidos
National Institute on Drug Abuse (NIDA) - Estados Unidos
Johns Hopkins University School of Medicine - Estados Unidos
4 Arab, Juanpablo Hombre Brown Univ - Estados Unidos
Pontificia Universidad Católica de Chile - Chile
Escuela de Medicina - Chile
5 Kuo, Yong-Fang Hombre Univ Texas Med Branch - Estados Unidos
UT Medical Branch at Galveston - Estados Unidos
The University of Texas Medical Branch at Galveston - Estados Unidos
6 Shah, Vijay H. Hombre Mayo Clin - Estados Unidos
Mayo Clinic - Estados Unidos

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
National Institute on Drug Abuse
Chilean government through the Fondo Nacional de Desarrollo Cientifico y Tecnologico
National Institute on Alcohol Abuse and Alcoholism
National Institute on Drug Abuse (NIDA)
National Institute On Alcohol Abuse And Alcoholism (NIAAA)
Agencia Nacional de Investigacion y Desarrollo, ANID

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
L.L. is a US federal employee at the NIH and he is jointly funded by the intramural research programs of the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA; ZIA-DA000635 and ZIAAA000218). This article was partially supported by the Chilean government through the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1200227 to J. P.A.) and the Agencia Nacional de Investigacion y desarrollo, ANID through ANID ACE 210009 grant (to J.P.A.).

Muestra la fuente de financiamiento declarada en la publicación.